Hilary A. Kenny

7.2k total citations · 4 hit papers
41 papers, 5.4k citations indexed

About

Hilary A. Kenny is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hilary A. Kenny has authored 41 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 14 papers in Molecular Biology and 13 papers in Cancer Research. Recurrent topics in Hilary A. Kenny's work include Cancer Cells and Metastasis (11 papers), Ovarian cancer diagnosis and treatment (9 papers) and Protease and Inhibitor Mechanisms (7 papers). Hilary A. Kenny is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Ovarian cancer diagnosis and treatment (9 papers) and Protease and Inhibitor Mechanisms (7 papers). Hilary A. Kenny collaborates with scholars based in United States, Germany and Italy. Hilary A. Kenny's co-authors include Ernst Lengyel, S. Diane Yamada, András Ladányi, Iris L. Romero, Kristin M. Nieman, Marcus E. Peter, Marion Zillhardt, Carla Penicka, Katja Gwin and Gordon B. Mills and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hilary A. Kenny

38 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

2011 1.7k citations Kristin M. Nieman, Hilary A. Kenny et al. profile →
Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis

2018 381 citations András Ladányi, Abir Mukherjee et al. Oncogene profile →
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum

2018 345 citations Hilary A. Kenny, Ernst Lengyel et al. profile →
Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis

2021 216 citations Hilary A. Kenny, Ernst Lengyel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hilary A. Kenny United States	27	2.6k	2.1k	1.8k	1.1k	781	41	5.4k
Thierry Maudelondé France	41	2.2k 0.8×	1.9k 0.9×	2.2k 1.2×	537 0.5×	439 0.6×	125	5.1k
Isabelle Treilleux France	47	3.1k 1.2×	1.7k 0.8×	3.6k 2.0×	2.3k 2.2×	393 0.5×	219	7.9k
Daniel Rosen United States	37	2.6k 1.0×	1.0k 0.5×	1.5k 0.8×	608 0.6×	1.0k 1.3×	87	4.9k
Oriol Casanovas Spain	32	3.8k 1.4×	2.1k 1.0×	2.3k 1.3×	591 0.6×	137 0.2×	70	6.2k
András Ladányi United States	16	1.6k 0.6×	1.8k 0.8×	1.4k 0.8×	404 0.4×	302 0.4×	26	3.5k
M. OʼReilly United States	14	3.7k 1.4×	2.2k 1.0×	1.9k 1.0×	719 0.7×	120 0.2×	30	6.0k
Patrizia Casalini Italy	38	3.0k 1.1×	2.5k 1.2×	1.7k 0.9×	1.0k 1.0×	146 0.2×	79	5.3k
Bjørn Risberg Norway	41	1.8k 0.7×	877 0.4×	1.4k 0.8×	556 0.5×	788 1.0×	131	4.6k
Viví Ann Flørenes Norway	42	3.5k 1.3×	1.0k 0.5×	2.2k 1.2×	620 0.6×	255 0.3×	108	5.4k
Kaisa Lehti Finland	38	2.0k 0.7×	2.0k 1.0×	1.9k 1.1×	436 0.4×	119 0.2×	85	4.4k

Countries citing papers authored by Hilary A. Kenny

Since Specialization

Citations

This map shows the geographic impact of Hilary A. Kenny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary A. Kenny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary A. Kenny more than expected).

Fields of papers citing papers by Hilary A. Kenny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilary A. Kenny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary A. Kenny. The network helps show where Hilary A. Kenny may publish in the future.

Co-authorship network of co-authors of Hilary A. Kenny

This figure shows the co-authorship network connecting the top 25 collaborators of Hilary A. Kenny. A scholar is included among the top collaborators of Hilary A. Kenny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hilary A. Kenny. Hilary A. Kenny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kenny, Hilary A., Carman Ka Man Ip, Frances R. Balkwill, et al.. (2025). Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth. Molecular Cancer Therapeutics. 24(8). 1252–1264.

Battistini, Chiara, Hilary A. Kenny, Alessandra Decio, et al.. (2024). Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness. Cell Death and Disease. 15(5). 370–370. 6 indexed citations

Shimizu, Aasa, et al.. (2024). Spatial transcriptomics characterizes high-grade serous ovarian cancer and its precursor lesions. Gynecologic Oncology. 190. S94–S95.

Lastra, Ricardo R., et al.. (2023). Cancer-associated mesothelial cell–derived ANGPTL4 and STC1 promote the early steps of ovarian cancer metastasis. JCI Insight. 8(6). 28 indexed citations

Kenny, Hilary A., Peter C. Hart, Madhu Lal, et al.. (2021). The Natural Product β-Escin Targets Cancer and Stromal Cells of the Tumor Microenvironment to Inhibit Ovarian Cancer Metastasis. Cancers. 13(16). 3931–3931. 20 indexed citations

Hart, Peter C., et al.. (2021). Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity. Advances in experimental medicine and biology. 1330. 75–94. 3 indexed citations

Kenny, Hilary A., Madhu Lal‐Nag, Min Shen, et al.. (2019). Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis. Molecular Cancer Therapeutics. 19(1). 52–62. 22 indexed citations

McGuire, Sean E., Peter C. Hart, Anthony Montag, et al.. (2019). Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis. Gynecologic Oncology. 153(2). 405–415. 29 indexed citations

Watters, Karen M., et al.. (2018). Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment. Cancers. 10(8). 265–265. 40 indexed citations

10.

Ladányi, András, Abir Mukherjee, Hilary A. Kenny, et al.. (2018). Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 37(17). 2285–2301. 381 indexed citations breakdown →

11.

McGee, Lauren, et al.. (2017). A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth. SLAS DISCOVERY. 22(5). 494–506. 25 indexed citations

12.

Lengyel, Ernst, et al.. (2015). Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity. Journal of Visualized Experiments. e53541–e53541. 16 indexed citations

13.

Kenny, Hilary A., Erin A. White, Min Shen, et al.. (2015). Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy. Nature Communications. 6(1). 10649–10649. 131 indexed citations

14.

Zhang, Yilin, Hilary A. Kenny, Elden P. Swindell, et al.. (2013). Urokinase Plasminogen Activator System–Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapy. Molecular Cancer Therapeutics. 12(12). 2628–2639. 33 indexed citations

15.

Kenny, Hilary A., András Ladányi, S. Diane Yamada, et al.. (2010). Targeting the Urokinase Plasminogen Activator Receptor Inhibits Ovarian Cancer Metastasis. Clinical Cancer Research. 17(3). 459–471. 65 indexed citations

16.

Kenny, Hilary A., Marion Zillhardt, Anirban Mitra, et al.. (2009). Organotypic Models of Metastasis: A Three-dimensional Culture Mimicking the Human Peritoneum and Omentum for the Study of the Early Steps of Ovarian Cancer Metastasis. Cancer treatment and research. 149. 335–351. 81 indexed citations

17.

Kenny, Hilary A. & Ernst Lengyel. (2009). MMP-2 functions as an early response protein in ovarian cancer metastasis. Cell Cycle. 8(5). 683–688. 123 indexed citations

18.

Sawada, Kenjiro, Anirban Mitra, A. Reza Radjabi, et al.. (2008). Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target. Cancer Research. 68(7). 2329–2339. 303 indexed citations

19.

Kenny, Hilary A., Swayamjot Kaur, Lisa M. Coussens, & Ernst Lengyel. (2008). The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. Journal of Clinical Investigation. 118(4). 1367–1379. 291 indexed citations

20.

Kenny, Hilary A., Sujatha Jagadeeswaran, Andrew P. Mazar, & Ernst Lengyel. (2007). Treatment with an uPAR (ATN 658) antibody inhibits ovarian cancer metastasis.. Molecular Cancer Therapeutics. 6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact